Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 11, S35-S38
- https://doi.org/10.1097/00001721-200004001-00008
Abstract
Six hemophilia A patients with inhibitors were treated with a continuous infusion of recombinant activated factor VII (rFVIIa) for various bleeding episodes. Bleeding episodes (n= 101) were treated according to a 12 h regular dose protocol or a shortened (6 h) augmented dose protocol. Patient response to therapy was assessed by symptomatic improvement within predefined timeframes. Although patient number was limited, both protocols appeared similar with respect to the proportion of patients responding to therapy; however, the augmented dose protocol appeared to be superior to the regular dose protocol with shorter response time, shorter duration of therapy and possibly lower rFVIIa requirements. Further studies are needed to define the efficacy of rFVIIa augmented dose administered as continuous infusion in treating hemophilia patients with inhibitors during major bleeding episodes, trauma and surgery.Keywords
This publication has 13 references indexed in Scilit:
- Safety, efficacy and lessons from continuous infusion with rFVIIaHaemophilia, 1998
- Clinical experience with recombinant factor VIIaBlood Coagulation & Fibrinolysis, 1998
- Prospective, Randomised Trial of Two Doses of rFVIIa (NovoSeven) in Haemophilia Patients with Inhibitors Undergoing SurgeryThrombosis and Haemostasis, 1998
- Platelet activity of high‐dose factor VIIa is independent of tissue factorBritish Journal of Haematology, 1997
- Clinical update on the use of recombinant factor VIIPublished by Springer Nature ,1995
- Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIIIThe Lancet, 1991
- Experiences with Recombinant Factor VIIa in HaemophiliacsPublished by S. Karger AG ,1990
- Factor VIIa in the treatment of haemophiliaBlood Coagulation & Fibrinolysis, 1990
- Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIaBlood, 1990
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988